Recapping the Crohn's & Colitis Congress®

In January, the Crohn’s & Colitis Foundation and American Gastroenterological Association (AGA) convened its annual Crohn’s & Colitis Congress®, the premier meeting in inflammatory bowel disease (IBD). Due to COVID-19, this year’s meeting went virtual and brought together more people than ever – more than 1,400 IBD health professionals and researchers came together from over 35 countries to discuss the latest research about Crohn’s disease and ulcerative colitis.

Over the course of four days, attendees were able to watch sessions on a variety of topics, including challenges and new approaches to managing IBD in the COVID-19 era, the future of IBD treatments, holistic view of IBD, health literacy, diet and nutrition, mental health, and more. Additionally, participants could view abstract presentations and case-based panel sessions based on their level of IBD experience. 

Below is a recap of some of the latest advancements and findings that were shared during the meeting:

In addition, much of this research presented at Congress was also included in our IBD Insider: Patient Updates from the 2021 Crohn’s & Colitis Congress®. Read more about this program here.   

The Crohn’s & Colitis Congress® will take place January 20-22, 2022 in Las Vegas. We can’t wait to see what new discoveries are made between now and then to help us improve patient care, develop better treatments, and bring us closer to IBD cures.